Our operating team.
.jpg)
John Boghossian
Chief Executive Officer
​
Dr Ryan Protzko
President
​
Hans-Juergen Gruss
Chief Medical Officer
​
Dr Chris Hayes
Chief IP Officer
​
Leonie Woodfinden
Director, Strategy and Operations
Emma Cheetham
Director, IP
​
Fraser Boistelle
Senior Manager, Business Development and Operations
Karma Chalabi
Associate, R&D and Operations
​
Our board of directors.
Lars Wilde
Chairman
-
CEO, Pangea Bio
-
Co-founder and President, COMPASS Pathways
-
Co-founder, atai Life Sciences, mental health drug development
-
Former Waterland Private Equity and BCG
​
​
Sabine Luik
Non-Executive Director
-
Chief Medical Officer, Senior VP Global Medical, Regulatory and Quality, GSK
-
Former Senior VP Medicine and Regulatory Affairs, Boehringer Ingelheim
​​
Adam George
Non-Executive Director
-
Former CFO and UK Managing Director, GW Pharmaceuticals
-
Audit Committee Chairman, NuCana Plc
-
BSc in Biology, University of Bristol
​
Max de Vere
Investor Director
-
Co-founder and Partner, re.Mind Capital
-
Former Apeiron Investments and McKinsey
-
M.Math in Mathematics, University of Oxford
​
​
​
Manon Veraart
Director
-
CBO, Pangea Bio
-
Former CBO, Quercis Pharma
-
Former Business Development at Compass Pathways, Goldman Sachs, and BCG
-
MBA INSEAD, MSc Neuroscience King's College London
​
​
Dr Nigel Gericke
Founding CSO
-
Founding CSO, Kanna Health
-
Ethnopharmacologist, Medical doctor, world expert in the pharmacology and clinical applications of kanna
-
MBBCh, University of Witwatersrand
​
​
​
.jpg)
​John Boghossian
Chief Executive Officer
-
CEO, Kanna Health
-
Former CEO, Quercis Pharma
-
Former VP of Operations, Compass Pathways
-
Former Consultant at BCG
-
MBA, Harvard Business Schoo; MSc Engineering, Cambridge University; BSc Mechanical Engineering and Economics, MIT
​Dr Ryan Protzko
President
-
President, Kanna Health
-
Founder, New Atlas Biotechnologies
-
Co-founder, Zestbio
-
PhD Molecular and Cell Biology, UC Berkeley
​
​
​
​
Our scientific advisors.
Dr Ian Osterloh
-
Former Director of Sexual Health at Pfizer
-
Responsible for the clinical strategy, and European regulatory filings for Viagra for treatment of erectile dysfunction
-
Led Phase I and Phase II programme for candidate treatment for PE
Dr Chris McMahon
-
Former President of the ISSM
-
Author of 20+ book chapters and 100+ research articles
-
More than 30 years experience in sexual health, including in major international clinical trials in PE
​
​
​
Dr Andrea Burri
-
ESSM certified psycho-sexologist, with more than 15 years experience in sex therapy
-
More than 140 peer-reviewed publications in the field of sexual health
-
Internationally renowned speaker on sex-related topics
​
​
Prof Stanley Althof
-
More than 35 years clinical experience treating patients with sexual dysfunction
-
Author of over 160 peer reviewed original publications
-
Author of ISSM guidelines for diagnosis and treatment of PE
​
​
​
Prof Geoff Hackett
-
Past President of the BSSM and current member of the executive committee of the ESSM
-
More than 130 peer reviewed original publications in sexual medicine
​
​
​
​
Prof Jim Pfaus
-
Preclinical researcher in behavioural neuroscience, focused on sexual behaviour
-
Past President of the International Academy of Sex Research
-
Editor-in-Chief, Current Sexual Health Reports
​
​
Dr Michael Perelman
-
Emeritus Clinical Professor of Psychiatry, Cornell Medicine; Director, Human Sexuality program
-
Founder, MAP Education and Research Foundation
​
​
​
​